Yuma Kameyama Selected Research

Gemcitabine

3/2022

Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuma Kameyama Research Topics

Disease

1	Triple Negative Breast Neoplasms 03/2024
1	Breast Neoplasms (Breast Cancer) 03/2024
1	Disseminated Intravascular Coagulation 03/2024
1	Dyspnea (Shortness of Breath) 03/2024
1	Neoplasms (Cancer) 03/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2024
1	Thrombotic Microangiopathies 03/2024
1	Liver Cell Adenoma (Hepatocellular Adenoma) 04/2023
1	Peritoneal Neoplasms 03/2022
1	Gallbladder Neoplasms (Gallbladder Cancer) 03/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 03/2022

Drug/Important Bio-Agent (IBA)

1	Dacarbazine (DIC)FDA LinkGeneric 03/2024
1	Capecitabine (Xeloda)FDA Link 03/2024
1	CateninsIBA 04/2023
1	Cisplatin (Platino)FDA LinkGeneric 03/2022
1	Gemcitabine FDA Link 03/2022

Therapy/Procedure

1	Adjuvant Chemotherapy 03/2024
1	Neoadjuvant Therapy 03/2024
1	Therapeutics 03/2022
1	Drug Therapy (Chemotherapy) 03/2022
1	Chemoradiotherapy 03/2022